06/18/2014 | Sponsored by Alimera
Diabetic maculopathy is the most common cause of visual impairment in individuals with diabetes.
06/17/2014 | Mark Hillen
What does analysis of the last five years of the literature on keratoconus tell us about the priorities of the field and the major contributors to it?
06/17/2014 | Carlos Buznego
Concomitant ocular diseases present an increasingly common challenge.
In August, The Ophthalmologist will publish a special issue showcasing the very best images from the field of ophthalmology.
Common yoga positions significantly raise IOP for prolonged periods
The body’s own regulatory T-lymphocytes, known as Tregs, can be taught to douse inflammation.
The visual cortex processes auditory information – both real and imaginary
05/19/2014 | Mark Hillen
What does analysis of the last five years of the literature on Stargardt Disease tell us about the priorities of the field and the major contributors to it?
05/19/2014 | Farhad Hafezi
The concept of using photoactivated chromophores for corneal cross-linking (PACK-CXL) as a weapon against infectious keratitis is compelling. The evidence suggests that PACK-CXL could have a dramatic impact on a major cause of global blindness… but only if the expensive, bulky technology (and the requirement for a corneal surgeon in a sterile operating theater) can be overcome. One company may have the answer.
05/19/2014 | Florian Kretz, Sibylle Scholtz, Gerd Auffarth
The development and use of intraocular lenses has been a major ophthalmic success story. Here, we describe some of the key contributions and the materials that revolutionized cataract treatment.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: